Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Rilpivirine. Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination therapy for the treatment of HIV-1 infection in antiretroviral-naïve adults and adolescents. It works by binding to HIV-1 reverse transcriptase, causing conformational changes that inhibit viral DNA synthesis. Rilpivirine has good oral absorption and is typically taken once daily with food to enhance bioavailability. It offers a favorable side-effect profile compared to older NNRTIs, with common effects including depression, insomnia, headache, and rash. The drug has significant interactions with acid-reducing agents and CYP3A inducers. Rilpivirine is also used as part of long-acting injectable regimens (in combination with cabotegravir) for maintenance therapy. Its high resistance barrier and tolerability make it suitable for long-term HIV management. Buy high quality Rilpivirine from Omsynth Lifesciences.